Vestibular Anatomic Localization of Pain Sensitivity in Women with Insertional Dyspareunia: A Different Approach to Address the Variability of Painful Intercourse
暂无分享,去创建一个
[1] A. Paetau,et al. Immune activation enhances epithelial nerve growth in provoked vestibulodynia. , 2016, American journal of obstetrics and gynecology.
[2] C. Pukall,et al. Non-Medical, Medical, and Surgical Approaches for the Treatment of Provoked Vestibulodynia , 2016, Current Sexual Health Reports.
[3] S. Witkin,et al. Recent advances in understanding provoked vestibulodynia , 2016, F1000Research.
[4] J. Bornstein,et al. 2015 ISSVD, ISSWSH and IPPS Consensus Terminology and Classification of Persistent Vulvar Pain and Vulvodynia , 2016, Obstetrics and gynecology.
[5] Candace S. Brown,et al. Vulvodynia: Assessment and Treatment. , 2016, The journal of sexual medicine.
[6] G. Bachmann,et al. Vulvodynia: Definition, Prevalence, Impact, and Pathophysiological Factors. , 2016, The journal of sexual medicine.
[7] S. As-Sanie,et al. Mucosal versus muscle pain sensitivity in provoked vestibulodynia , 2015, Journal of pain research.
[8] M. Morin,et al. Active and Passive Components of Pelvic Floor Muscle Tone in Women with Provoked Vestibulodynia: A Perspective Based on a Review of the Literature. , 2015, The journal of sexual medicine.
[9] I. Goldstein,et al. Polymorphisms of the androgen receptor gene and hormonal contraceptive induced provoked vestibulodynia. , 2014, The journal of sexual medicine.
[10] R. Rubin,et al. Current Uses of Surgery in the Treatment of Genital Pain , 2014, Current Sexual Health Reports.
[11] D. Foster,et al. Vulvodynia: Current state of the biological science , 2014, PAIN®.
[12] H. Lawson,et al. 2013 Vulvodynia Guideline Update , 2014, Journal of lower genital tract disease.
[13] L. Burrows,et al. The Treatment of Vestibulodynia with Topical Estradiol and Testosterone , 2013, Sexual medicine.
[14] G. Essick,et al. Reliability and reproducibility of novel methodology for assessment of pressure pain sensitivity in pelvis. , 2012, The journal of pain : official journal of the American Pain Society.
[15] L. Burrows,et al. The effects of hormonal contraceptives on female sexuality: a review. , 2012, The journal of sexual medicine.
[16] K. Nilsson,et al. Provoked vestibulodynia--medical factors and comorbidity associated with treatment outcome. , 2012, The journal of sexual medicine.
[17] Ananda Sen,et al. Prevalence and demographic characteristics of vulvodynia in a population-based sample. , 2012, American journal of obstetrics and gynecology.
[18] G. Donders,et al. Characteristics of the pain observed in the focal vulvodynia syndrome (VVS). , 2012, Medical Hypotheses.
[19] T. Morgan,et al. Differences in Primary Compared With Secondary Vestibulodynia by Immunohistochemistry , 2011, Obstetrics and gynecology.
[20] J. Andrews. Vulvodynia Interventions—Systematic Review and Evidence Grading , 2011, Obstetrical & gynecological survey.
[21] G. Ohel,et al. The association between supra‐physiological levels of estradiol and response patterns to experimental pain , 2010, European journal of pain.
[22] I. Goldstein,et al. Can oral contraceptives cause vestibulodynia? , 2010, The journal of sexual medicine.
[23] L. McLean,et al. Pelvic floor muscle assessment outcomes in women with and without provoked vestibulodynia and the impact of a physical therapy program. , 2010, The journal of sexual medicine.
[24] A. Goldstein. Moving beyond the diagnosis of vestibulodynia--a holiday wish list. , 2009, The journal of sexual medicine.
[25] L. Burrows,et al. Umbilical hypersensitivity in women with primary vestibulodynia. , 2008, The Journal of reproductive medicine.
[26] A. Vitonis,et al. Influence of oral contraceptive use on the risk of adult-onset vulvodynia. , 2008, The Journal of reproductive medicine.
[27] A. Malykhina. Neural mechanisms of pelvic organ cross-sensitization , 2007, Neuroscience.
[28] R. Craft. Modulation of pain by estrogens , 2007, PAIN.
[29] Z. Ben-Aroya,et al. Vulvar vestibulitis syndrome and estrogen dose of oral contraceptive pills. , 2007, The journal of sexual medicine.
[30] M. Hilliges,et al. The vulval vestibular mucosa—morphological effects of oral contraceptives and menstrual cycle , 2007, The British journal of dermatology.
[31] M. Granot,et al. Psychological Factors Associated with Perception of Experimental Pain in Vulvar Vestibulitis Syndrome , 2005, Journal of sex & marital therapy.
[32] Y. Binik,et al. Pelvic floor muscle functioning in women with vulvar vestibulitis syndrome , 2005, Journal of psychosomatic obstetrics and gynaecology.
[33] I. Ben‐Ami,et al. The Major Histopathologic Characteristics in the Vulvar Vestibulitis Syndrome , 2005, Gynecologic and Obstetric Investigation.
[34] E. Torebjörk,et al. Decreased mechanical pain threshold in the vestibular mucosa of women using oral contraceptives: a contributing factor in vulvar vestibulitis? , 2004, The Journal of reproductive medicine.
[35] J. Bornstein,et al. Hyperinnervation and Mast Cell Activation May Be Used as Histopathologic Diagnostic Criteria for Vulvar Vestibulitis , 2004, Gynecologic and Obstetric Investigation.
[36] Y. Binik,et al. Vaginal Spasm, Pain, and Behavior: An Empirical Investigation of the Diagnosis of Vaginismus , 2004, Archives of sexual behavior.
[37] G. Terenghi,et al. Increased innervation of the vulval vestibule in patients with vulvodynia , 2003, The British journal of dermatology.
[38] H. Stenlund,et al. Prevalence and incidence of prolonged and severe dyspareunia in women: results from a population study , 2003, Scandinavian journal of public health.
[39] J. Brisson,et al. Use of oral contraceptive pills and vulvar vestibulitis: a case-control study. , 2002, American journal of epidemiology.
[40] R. Amsel,et al. Vestibular tactile and pain thresholds in women with vulvar vestibulitis syndrome , 2002, Pain.
[41] L. Wise,et al. Prevalence and predictors of chronic lower genital tract discomfort. , 2001, American journal of obstetrics and gynecology.
[42] M. Hilliges,et al. Neurochemical Characterization of the Vestibular Nerves in Women with Vulvar Vestibulitis Syndrome , 1999, Gynecologic and Obstetric Investigation.
[43] E. Laumann,et al. Sexual dysfunction in the United States: prevalence and predictors. , 1999, JAMA.
[44] M. Hilliges,et al. Increased Intraepithelial Innervation in Women with Vulvar Vestibulitis Syndrome , 1998, Gynecologic and Obstetric Investigation.
[45] R. Willén,et al. Vestibular Nerve Fiber Proliferation in Vulvar Vestibulitis Syndrome , 1998, Obstetrics and gynecology.
[46] I. Sjöberg,et al. Vulvar vestibulitis in the north of Sweden. An epidemiologic case-control study. , 1997, The Journal of reproductive medicine.
[47] J. Brisson,et al. Vulvar Vestibulitis Syndrome: An Exploratory Case-Control Study , 1994, Obstetrics and gynecology.
[48] L. Fertitta,et al. Vulvar vestibulitis syndrome. , 1992, Nurse practitioner forum.
[49] L. Grillo,et al. Mangement of dyspareunia secondary to hymenal remnants. , 1980, Obstetrics and Gynecology.